These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 22156701)

  • 1. The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature.
    Edwards NJ; Kamel H; Josephson SA
    Stroke; 2012 Feb; 43(2):412-6. PubMed ID: 22156701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms.
    Mittal MK; Seet RC; Zhang Y; Brown RD; Rabinstein AA
    J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):639-43. PubMed ID: 22341666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is acute reperfusion therapy safe in acute ischemic stroke patients who harbor unruptured intracranial aneurysm?
    Mowla A; Singh K; Mehla S; Ahmed MK; Shirani P; Kamal H; Krishna C; Sawyer RN; Ching M; Siddiqui AH; Levy EI; Snyder KV; Crumlish A; Hopkins LN
    Int J Stroke; 2015 Oct; 10 Suppl A100():113-8. PubMed ID: 26377963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic thrombolysis in acute ischemic stroke patients with unruptured intracranial aneurysms.
    Goyal N; Tsivgoulis G; Zand R; Sharma VK; Barlinn K; Male S; Katsanos AH; Bodechtel U; Iftikhar S; Arthur A; Elijovich L; Alexandrov AW; Alexandrov AV
    Neurology; 2015 Oct; 85(17):1452-8. PubMed ID: 26408492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous rt-PA is not associated with increased risk of hemorrhage in patients with intracranial aneurysms.
    Sheth KN; Shah N; Morovati T; Hermann LD; Cronin CA
    Neurocrit Care; 2012 Oct; 17(2):199-203. PubMed ID: 22752394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of tissue plasminogen activator factor in an acute stroke patient with two unruptured cerebral aneurysms.
    Sonbaa AM; Khayat AF; Almekhlafi MA
    Neurosciences (Riyadh); 2018 Oct; 23(4):334-337. PubMed ID: 30351292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and significance of incidental unruptured cerebral aneurysms in patients undergoing intravenous thrombolysis for acute ischemic stroke.
    Kim JT; Park MS; Yoon W; Cho KH
    J Neuroimaging; 2012 Apr; 22(2):197-200. PubMed ID: 21143548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it dangerous to treat acute ischemic stroke by thrombolytic therapy in patients with comorbid intracranial aneurysms?
    Ding J; Han J; Jing Z; Jiang Y
    Am J Emerg Med; 2016 Mar; 34(3):636-42. PubMed ID: 26795887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtherapeutic warfarin is not associated with increased hemorrhage rates in ischemic strokes treated with tissue plasminogen activator.
    Vergouwen MD; Casaubon LK; Swartz RH; Fang J; Stamplecoski M; Kapral MK; Silver FL;
    Stroke; 2011 Apr; 42(4):1041-5. PubMed ID: 21350204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report.
    Matsuzaki T; Yoshino A; Sakatani K; Katayama Y
    J Stroke Cerebrovasc Dis; 2011; 20(3):269-72. PubMed ID: 20630773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results From a Multicenter Study.
    Prats-Sánchez L; Camps-Renom P; Sotoca-Fernández J; Delgado-Mederos R; Martínez-Domeño A; Marín R; Almendrote M; Dorado L; Gomis M; Codas J; Llull L; Gómez González A; Roquer J; Purroy F; Gómez-Choco M; Cánovas D; Cocho D; Garces M; Abilleira S; Martí-Fàbregas J;
    Stroke; 2016 Aug; 47(8):2003-9. PubMed ID: 27406103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of antithrombotic therapy for patients with acute ischemic stroke harboring unruptured intracranial aneurysm.
    Shono Y; Sugimori H; Matsuo R; Fukushima Y; Wakisaka Y; Kuroda J; Ago T; Kamouchi M; Kitazono T
    Int J Stroke; 2018 Oct; 13(7):734-742. PubMed ID: 29543141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Early Arterial Recanalization and Tissue Fate in the Selection of Patients With the Greatest Potential to Benefit From Intravenous Tissue-Type Plasminogen Activator.
    Leiva-Salinas C; Patrie JT; Xin W; Michel P; Jovin T; Wintermark M
    Stroke; 2016 Feb; 47(2):397-403. PubMed ID: 26696647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal intracranial aneurysm rupture after thrombolytic treatment for ischemic stroke: a case report and literature review.
    Beneš V; Jurák L; Jedlička J; Dienelt J; Suchomel P
    Acta Neurochir (Wien); 2019 Jul; 161(7):1337-1341. PubMed ID: 31065893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator.
    Menon BK; Saver JL; Prabhakaran S; Reeves M; Liang L; Olson DM; Peterson ED; Hernandez AF; Fonarow GC; Schwamm LH; Smith EE
    Stroke; 2012 Sep; 43(9):2293-9. PubMed ID: 22811458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.